Image

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to evaluate the effects of Blood Flow Restriction (BFR) training on walking function, health-related quality of life, and safety among adults with Peripheral Arterial Disease (PAD).

The main aims of the study are:

  1. Evaluate change in walking function among patients with PAD undergoing BFR training. The investigators will assess change in Six-Minute Walk Test (6MWT) distance from baseline to post-intervention and 3-month follow-up to compare functional improvements between the BFR group and the two control groups
  2. Assess changes in health-related quality of life among patients with PAD undergoing BFR training. The investigators will use the EuroQol 5-Dimension 5-Level (EQ-5D-5L) scale to evaluate quality-of-life changes from baseline to post-intervention and 3-month follow-up across all study arms
  3. Evaluate the safety and feasibility of a supervised BFR training program for patients with PAD. The investigators will compare adverse event (AE) and serious adverse event (SAE) rates across study arms, while also monitoring sessional ratings of perceived exertion (RPE), dyspnea, and claudication pain as indicators of symptom response and exercise tolerance. Feasibility will be assessed through enrollment success, intervention adherence, and retention rates across groups

Eligibility

Inclusion Criteria:

  1. 18 years of age or older
  2. Diagnosed peripheral arterial disease with stable claudication (symptomatic presentation unchanged for 6 months)
  3. Ankle-brachial index (ABI) between 0.4 and 0.9.
  4. Eligible referral to cardiovascular or pulmonary rehabilitation
  5. Prior revascularization permitted if symptoms are stable and other criteria are met

Exclusion Criteria:

  1. Recent change in resting ECG suggesting significant ischemia, recent myocardial infarction (within 2 weeks), or another acute cardiac event
  2. Unstable angina
  3. Uncontrolled cardiac arrhythmias
  4. Symptomatic severe aortic stenosis or other significant valvular disease
  5. Decompensated symptomatic heart failure
  6. Acute pulmonary embolism or infarction
  7. Acute noncardiac disorder likely to interfere with or be worsened by exercise (e.g., infection, thyrotoxicosis)
  8. Acute myocarditis or pericarditis
  9. Acute thrombophlebitis
  10. Physical disability precluding safe or adequate exercise performance
  11. Significant electrolyte abnormalities
  12. Clinically significant tachyarrhythmias or bradyarrhythmias
  13. High-degree atrioventricular block
  14. Atrial fibrillation with uncontrolled ventricular response
  15. Hypertrophic obstructive cardiomyopathy with resting left ventricular outflow gradient of \>25 mmHg
  16. Known active aortic dissection
  17. Severe resting arterial hypertension (SBP\>200mmHg or DBP \>110 mmHg)
  18. Mental impairment preventing cooperation with study procedures
  19. Current pregnancy
  20. Moderate to severe peripheral neuropathy
  21. Open wounds or compromised skin near BFR cuff site
  22. Active DVT or thromboembolic event within the past year

Study details
    Peripheral Arterial Disease

NCT07223437

University of Tennessee Graduate School of Medicine

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.